
FT Global Pharmaceutical and Biotechnology Conference
pharmafile | June 28, 2017 | News story | Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing |Â Â Â
The FT Global Pharmaceutical and Biotechnology Conference, now in its 35th successful year brings together life science companies, their health industry counterparts and emerging new industry entrants to review the key challenges facing the industry, and the business models and transformation strategies that will be needed to survive and thrive in this new era of unprecedented disruption and uncertainty.
Speakers include:
Flemming Ornskov, Chief Executive Officer, Shire
Arie Belldegrun, Founder, Executive Chairman, Chief Executive Officer and President,
Kite Pharma
Rod MacKenzie, Executive Vice President, Chief Development Officer, Pfizer
Bélén Garijo, Member of the Board and CEO, Healthcare, The Merck Group
Bahija Jallal, Executive Vice President, AstraZeneca and Head , MedImmune
Hervé Hoppenot, President and Chief Executive Officer, Incyte Corp
Vivek Ramaswamy, Chief Executive Officer, Roivant Sciences
José Luis Molinuevo, Scientific Director, Barcelona Beta Brain Research Centre, Pasqual Maragall Foundation
Lihi Segal, Co-Founder & CEO, DayTwo
Pharmafile and Pharmafocus subscribers are entitled to a 10% discount which can be activated by using the code PHF10 at registration.
Event venue: The Landmark Hotel, London
Event website: live.ft.com/PharmaBio
Contact: Funmbi Adenubi, Financial Times at ftlive@ft.com
or tel +44 (0)20 7775 6653






